Complete as many rounds as possible in 20 minutes of:
Post rounds completed to comments.
Compare to 190412.
In this 2019 review, Thomas Seyfried et al. argue that, due to the significant drawbacks of the existing standard of care for glioblastoma multiforme (GBM) and the potential benefits of ketogenic metabolic therapy, ketogenic therapies should be tested in patients with GBM.Read MoreProvocative Question: Should Ketogenic Metabolic Therapy Become the Standard of Care for Glioblastoma?